Avanos Medical to Discuss Q4 and Full Year 2025 Earnings

The medical device company will host a webcast conference call to review financial results and business highlights.

Published on Feb. 17, 2026

Avanos Medical, Inc., a medical technology company focused on delivering clinically superior medical device solutions, will host a conference call on Tuesday, February 24, 2026 at 9 a.m. ET to discuss its financial results and business highlights for the fourth quarter and full year 2025. The company will issue a news release detailing its results before the market opens that same day.

Why it matters

As a leading medical device company, Avanos' quarterly and annual financial performance and business updates are closely watched by investors, analysts, and industry observers to gauge the company's competitive position and growth prospects in the healthcare technology market.

The details

The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer. Investors can join the call by phone using a provided link to register, or by dialing a specific number. A simultaneous webcast of the call and presentation will also be accessible on the company's investor relations website.

  • The conference call will be held on Tuesday, February 24, 2026 at 9 a.m. ET.
  • Avanos will issue its Q4 and full year 2025 financial results before the market opens on February 24, 2026.

The players

Avanos Medical, Inc.

A medical technology company focused on delivering clinically superior medical device solutions, headquartered in Alpharetta, Georgia.

Dave Pacitti

Chief executive officer of Avanos Medical.

Scott Galovan

Senior vice president and chief financial officer of Avanos Medical.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be able to access a replay of the conference call and webcast on the Avanos Medical investor relations website following the event.

The takeaway

Avanos Medical's quarterly and annual financial performance updates provide valuable insights into the company's strategic direction, product pipeline, and competitive positioning in the evolving medical device industry.